Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FROG | Ordinary Shares | Options Exercise | $19K | +8K | +1.58% | $2.38 | 515K | Nov 16, 2023 | Direct | |
transaction | FROG | Ordinary Shares | Sale | -$215K | -8K | -1.55% | $26.84 | 507K | Nov 16, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FROG | Employer Share Option (right to buy) | Options Exercise | $0 | -8K | -2.55% | $0.00 | 306K | Nov 16, 2023 | Ordinary Shares | 8K | $2.38 | Direct | F3 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2022. |
F2 | This transaction was executed in multiple trades at prices ranging from $26.65 to $27.21. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F3 | The shares underlying the options were fully vested on May 7, 2023. |